Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 05-Jun-24 6:12 PM View:  | Recursion Pharmaceuticals, ... (RXRX) | 03-Jun-24 | Grant | 13,097 | -- | -- | 23% 56.31K to 69.41K | |
| 29-Apr-24 4:10 PM View: | Beam Therapeutics Inc. (BEAM) | 26-Apr-24 | Grant | 12,500 | -- | -- | 18% 70.14K to 82.64K | |
| 03-Apr-24 7:39 PM View: | Beam Therapeutics Inc. (BEAM) | 01-Apr-24 | Sale (Planned) | 5,446 | $32.12 | $174,926.00 | (7%) 75.58K to 70.14K | |
| 03-Apr-24 5:42 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 01-Apr-24 | Grant | 1,467 | -- | -- | 3% 54.85K to 56.31K | |
| 02-Apr-24 4:10 PM View: | Beam Therapeutics Inc. (BEAM) | 31-Mar-24 | Grant | 27,500 | -- | -- | 57% 48.08K to 75.58K | |
| 14-Jul-23 6:52 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 13-Jul-23 | Sale (Planned) | 8,275 | $12.59 | $104,143.00 | (13%) 63.12K to 54.85K | |
| 14-Jul-23 6:52 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 12-Jul-23 | Sale (Planned) | 108,725 | $12.03 | $1,308,270.00 | (63%) 171.85K to 63.12K | |
| 21-Jun-23 5:19 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 16-Jun-23 | Grant | 12,612 | -- | -- | 8% 159.24K to 171.85K | |
| 05-Apr-23 8:30 PM View: | Beam Therapeutics Inc. (BEAM) | 04-Apr-23 | Sale (Planned) | 2,186 | $29.09 | $63,597.50 | (4%) 49.3K to 47.12K | |
| 05-Apr-23 8:30 PM View: | Beam Therapeutics Inc. (BEAM) | 03-Apr-23 | Sale (Planned) | 2,454 | $30.31 | $74,380.70 | (5%) 51.76K to 49.3K | |
| 31-Mar-23 7:46 PM View: | Beam Therapeutics Inc. (BEAM) | 31-Mar-23 | Grant | 20,000 | -- | -- | 64% 31.28K to 51.28K | |
| 30-Jan-23 4:05 PM View: | Beam Therapeutics Inc. (BEAM) | 27-Jan-23 | Option Exercise | 36,152 | $13.68 | $494,559.00 | 116% 31.28K to 67.43K | |
| 30-Jan-23 4:05 PM View: | Beam Therapeutics Inc. (BEAM) | 27-Jan-23 | Planned Option Sale | 36,152 | $45.08 | $1,629,750.00 | (54%) 67.43K to 31.28K | |
| 30-Jan-23 4:05 PM View: | Beam Therapeutics Inc. (BEAM) | 26-Jan-23 | Option Exercise | 1,102 | $13.68 | $15,075.40 | 4% 31.28K to 32.38K | |
| 30-Jan-23 4:05 PM View: | Beam Therapeutics Inc. (BEAM) | 26-Jan-23 | Planned Option Sale | 1,102 | $45.16 | $49,763.20 | (3%) 32.38K to 31.28K | |
| 25-Jan-23 5:25 PM View: | Beam Therapeutics Inc. (BEAM) | 24-Jan-23 | Option Exercise | 14,810 | $13.68 | $202,601.00 | 47% 31.28K to 46.09K | |
| 25-Jan-23 5:25 PM View: | Beam Therapeutics Inc. (BEAM) | 24-Jan-23 | Planned Option Sale | 14,810 | $45.01 | $666,657.00 | (32%) 46.09K to 31.28K | |
| 25-Jan-23 5:25 PM View: | Beam Therapeutics Inc. (BEAM) | 23-Jan-23 | Option Exercise | 5,426 | $13.68 | $74,227.70 | 17% 31.28K to 36.7K | |
| 25-Jan-23 5:25 PM View: | Beam Therapeutics Inc. (BEAM) | 23-Jan-23 | Planned Option Sale | 5,426 | $45.02 | $244,290.00 | (15%) 36.7K to 31.28K | |
| 20-Jan-23 4:18 PM View: | Beam Therapeutics Inc. (BEAM) | 18-Jan-23 | Option Exercise | 39,886 | $13.68 | $545,640.00 | 103% 38.59K to 78.47K | |
| 20-Jan-23 4:18 PM View: | Beam Therapeutics Inc. (BEAM) | 18-Jan-23 | Planned Option Sale | 39,886 | $45.14 | $1,800,450.00 | (51%) 78.47K to 38.59K | |
| 20-Jan-23 4:18 PM View: | Beam Therapeutics Inc. (BEAM) | 18-Jan-23 | Sale (Planned) | 7,309 | $45.14 | $329,928.00 | (19%) 38.59K to 31.28K | |
| 05-Jan-23 6:24 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 03-Jan-23 | Grant | 1,821 | -- | -- | 1% 157.41K to 159.24K | |
| 05-Oct-22 9:12 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 03-Oct-22 | Grant | 1,265 | -- | -- | < 1% 156.15K to 157.41K | |
| 06-Jul-22 5:48 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 01-Jul-22 | Grant | 1,631 | -- | -- | 1% 154.52K to 156.15K | |
| 16-Jun-22 8:12 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 14-Jun-22 | Grant | 18,145 | -- | -- | 13% 136.37K to 154.52K | |
| 05-Apr-22 7:23 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 01-Apr-22 | Grant | 1,788 | -- | -- | 1% 134.59K to 136.37K | |
| 04-Apr-22 8:22 PM View: | Beam Therapeutics Inc. (BEAM) | 31-Mar-22 | Grant | 15,000 | -- | -- | 60% 25.07K to 40.06K | |
| 04-Apr-22 8:22 PM View: | Beam Therapeutics Inc. (BEAM) | 31-Mar-22 | Sale | 1,787 | $59.11 | $105,630.00 | (4%) 40.06K to 38.28K | |
| 05-Jan-22 8:41 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 03-Jan-22 | Grant | 763 | -- | -- | < 1% 133.82K to 134.59K | |
| 05-Oct-21 8:33 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 01-Oct-21 | Grant | 629 | -- | -- | < 1% 133.19K to 133.82K | |
| 06-Jul-21 5:00 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 01-Jul-21 | Grant | 382 | -- | -- | < 1% 132.81K to 133.19K | |
| 02-Jul-21 6:01 PM View: | Beam Therapeutics Inc. (BEAM) | 30-Jun-21 | Option Exercise | 30,000 | $13.68 | $410,400.00 | 121% 24.81K to 54.81K | |
| 02-Jul-21 6:01 PM View: | Beam Therapeutics Inc. (BEAM) | 30-Jun-21 | Market Option Sale (Planned) | 30,000 | $122.00 | $3,660,000.00 | (55%) 54.81K to 24.81K | |
| 30-Jun-21 6:00 PM View: | Beam Therapeutics Inc. (BEAM) | 28-Jun-21 | Option Exercise | 45,000 | $13.68 | $615,600.00 | 181% 24.81K to 69.81K | |
| 30-Jun-21 6:00 PM View: | Beam Therapeutics Inc. (BEAM) | 28-Jun-21 | Market Option Sale (Planned) | 45,000 | $107.69 | $4,846,020.00 | (64%) 69.81K to 24.81K | |
| 22-Apr-21 7:38 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 20-Apr-21 | Conversion | 6,250 | -- | -- | 5% 132.81K to 139.06K | |
| 22-Apr-21 7:38 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 20-Apr-21 | Conversion | 6,250 | -- | -- | (2%) 265.62K to 259.37K | |
| 22-Apr-21 7:38 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 20-Apr-21 | Acquisition (other) | 126,561 | -- | -- | 91% 139.06K to 265.62K | |
| 22-Apr-21 7:38 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 20-Apr-21 | Disposition (other) | 126,561 | -- | -- | (49%) 259.37K to 132.81K | |
| 19-Apr-21 7:23 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 16-Apr-21 | Grant | 6,250 | -- | -- | 5% 120.31K to 126.56K | |
| 02-Apr-21 5:11 PM View: | Beam Therapeutics Inc. (BEAM) | 31-Mar-21 | Grant | 17,500 | -- | -- | 239% 7.31K to 24.81K | |
| 05-Jan-21 5:40 PM View: | Beam Therapeutics Inc. (BEAM) | 04-Jan-21 | Option Exercise | 25,000 | $13.68 | $342,000.00 | 342% 7.31K to 32.31K | |
| 05-Jan-21 5:40 PM View: | Beam Therapeutics Inc. (BEAM) | 04-Jan-21 | Market Option Sale (Planned) | 25,000 | $81.78 | $2,044,480.00 | (77%) 32.31K to 7.31K | |
| 21-Sep-20 9:08 PM View: | Beam Therapeutics Inc. (BEAM) | 18-Sep-20 | Option Exercise | 7,309 | $13.68 | $99,987.10 | 100% 0 to 7.31K |